FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Fox News Poll: Democratic unity, Republican crossovers shape Ohio Senate race

Rubio warns risk of escalation in Russia-Ukraine war is ‘more real than it was two years ago’

Video: WNBA Punishes Brittney Griner for Manhandling Angel Reese in On-Court Clash

Former primary rival resurfaces to challenge scandal-plagued Graham Platner in Maine Senate race

‘A Lot of Complaints Had Been Made’: Henry Nowak’s Murderer Was Known to Cops, Had Been Arrested Previously, Never Charged

Detective arrested after allegedly pulling gun on fellow officer for microwaving fish at police station

Cold case of missing news anchor rocked by claim of confession in roadside meltdown: report

LATE BREAKING: ’60 Minutes’ Star Reporter Scott Pelley Fired After Mouthing Off to New Boss Chosen by Bari Weiss

WATCH: Rubio scorches claim Trump weighed finances in Iran decisions: ‘Not even for a millisecond’

Sex criminals, gang members abused child immigration program to enter US, DHS reveals

BREAKING VIDEO: UK Police Retreat as Brits Furious About Murder of Henry Nowak Take to Streets, Pelt Cops with Enormous Garbage Cans

Bessent clarifies threat against Bill Pulte: He said he was going to ‘kick his a**’

Aid group warns Ebola could have spread for three months before first cases were detected

Rubio grilled over Trump’s national security picks and foreign policy priorities: ‘It’s not funny, secretary’

Judge with intimate ties to Dem Party’s key Russia Hoax players behind latest anti-Trump decision

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”